Tycho Peterson
Stock Analyst at Jefferies
(4.69)
# 794
Out of 5,060 analysts
441
Total ratings
57.5%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Initiated Coverage: Buy | $110 | $86.60 | +27.02% | 1 | Oct 7, 2026 | |
| DHR Danaher | Reiterated: Buy | $210 | $229.04 | -8.31% | 20 | Sep 18, 2026 | |
| A Agilent Technologies | Reiterated: Hold | $155 | $172.97 | -10.39% | 19 | Sep 11, 2026 | |
| FRNM Freenome | Initiated Coverage: Buy | $17 | $11.75 | +44.68% | 1 | Aug 17, 2026 | |
| NTRA Natera | Reiterated: Buy | $275 → $330 | $393.44 | -16.12% | 14 | Aug 17, 2026 | |
| TXG 10x Genomics | Reiterated: Buy | $21 → $53 | $69.86 | -24.13% | 12 | Aug 7, 2026 | |
| QGEN Qiagen | Reiterated: Buy | n/a | $46.13 | - | 29 | Aug 6, 2026 | |
| BME: BBVA Banco Bilbao Vizcaya Argentaria, S.A. | Reiterated: Buy | €27.00 → €27.50 | €23.18 | +18.64% | 2 | Aug 4, 2026 | |
| MTD Mettler-Toledo International | Reiterated: Buy | $1,450 → $1,580 | $1,622.29 | -2.61% | 13 | Jul 31, 2026 | |
| AVTR Avantor | Upgraded: Hold | $8 → $13 | $16.42 | -20.83% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $225 → $245 | $235.00 | +4.26% | 7 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 → $630 | $690.00 | -8.70% | 28 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $70 | $43.12 | +62.34% | 2 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $145 → $150 | $262.54 | -42.87% | 23 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $100 | $63.64 | +57.13% | 9 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $285 → $275 | $353.70 | -22.25% | 4 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $13 | $12.91 | -3.18% | 13 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $30.56 | -8.38% | 1 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $35 | $64.72 | -45.92% | 1 | Apr 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $122.37 | -6.02% | 3 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $50 | $54.78 | -8.73% | 18 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 | $436.95 | +7.56% | 24 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 → $105 | $152.64 | -31.21% | 13 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $139 | $145.95 | -4.76% | 4 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $130 | $158.60 | -18.03% | 12 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.06 | +142.72% | 1 | Dec 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $117 | $98.12 | +19.24% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $300 | $317.95 | n/a | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310 | $288.89 | n/a | 1 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4.5 | $1.24 | n/a | 2 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.73 | n/a | 11 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 → $11 | $3.98 | n/a | 16 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $18 | $16.65 | n/a | 3 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $64.00 | n/a | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.79 | n/a | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $2.06 | n/a | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $165 | $175.42 | n/a | 5 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $6 | $3.61 | n/a | 3 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $35 → $18 | $17.89 | n/a | 3 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | - | n/a | 6 | Jul 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 → $315 | $170.18 | n/a | 6 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $8 | $3.50 | n/a | 2 | Apr 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $25 | $8.25 | n/a | 3 | Mar 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $18 | $6.73 | n/a | 2 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $15 | $0.7644 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $60 | $2.87 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $25 | $2.03 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $55 | $8.57 | n/a | 7 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $50 | $24.02 | n/a | 4 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $310 | $266.90 | n/a | 13 | Feb 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $100 → $65 | $132.75 | n/a | 5 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $333 | $426.70 | n/a | 19 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $375 → $390 | $300.15 | n/a | 6 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $30 | $22.90 | n/a | 3 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.1557 | n/a | 8 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $34 → $25 | $6.39 | n/a | 6 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $0.6242 | n/a | 1 | Aug 4, 2016 |
Edwards Lifesciences
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $110
Current: $86.60
Upside: +27.02%
Danaher
Sep 18, 2026
Reiterated: Buy
Price Target: $210
Current: $229.04
Upside: -8.31%
Agilent Technologies
Sep 11, 2026
Reiterated: Hold
Price Target: $155
Current: $172.97
Upside: -10.39%
Freenome
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $11.75
Upside: +44.68%
Natera
Aug 17, 2026
Reiterated: Buy
Price Target: $275 → $330
Current: $393.44
Upside: -16.12%
10x Genomics
Aug 7, 2026
Reiterated: Buy
Price Target: $21 → $53
Current: $69.86
Upside: -24.13%
Qiagen
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $46.13
Upside: -
Banco Bilbao Vizcaya Argentaria, S.A.
Aug 4, 2026
Reiterated: Buy
Price Target: €27.00 → €27.50
Current: €23.18
Upside: +18.64%
Mettler-Toledo International
Jul 31, 2026
Reiterated: Buy
Price Target: $1,450 → $1,580
Current: $1,622.29
Upside: -2.61%
Avantor
Jul 29, 2026
Upgraded: Hold
Price Target: $8 → $13
Current: $16.42
Upside: -20.83%
Jul 23, 2026
Reiterated: Buy
Price Target: $225 → $245
Current: $235.00
Upside: +4.26%
Jul 23, 2026
Reiterated: Buy
Price Target: $650 → $630
Current: $690.00
Upside: -8.70%
Jul 8, 2026
Reiterated: Buy
Price Target: $45 → $70
Current: $43.12
Upside: +62.34%
Jul 1, 2026
Reiterated: Hold
Price Target: $145 → $150
Current: $262.54
Upside: -42.87%
May 27, 2026
Reiterated: Buy
Price Target: $150 → $100
Current: $63.64
Upside: +57.13%
May 21, 2026
Reiterated: Hold
Price Target: $285 → $275
Current: $353.70
Upside: -22.25%
May 7, 2026
Downgraded: Hold
Price Target: $35 → $13
Current: $12.91
Upside: -3.18%
Apr 12, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $30.56
Upside: -8.38%
Apr 12, 2026
Initiated Coverage: Sell
Price Target: $35
Current: $64.72
Upside: -45.92%
Mar 11, 2026
Reiterated: Buy
Price Target: $115
Current: $122.37
Upside: -6.02%
Feb 12, 2026
Reiterated: Buy
Price Target: $60 → $50
Current: $54.78
Upside: -8.73%
Feb 10, 2026
Reiterated: Buy
Price Target: $470
Current: $436.95
Upside: +7.56%
Feb 2, 2026
Reiterated: Hold
Price Target: $100 → $105
Current: $152.64
Upside: -31.21%
Dec 19, 2025
Reiterated: Buy
Price Target: $139
Current: $145.95
Upside: -4.76%
Dec 17, 2025
Reiterated: Buy
Price Target: $75 → $130
Current: $158.60
Upside: -18.03%
Dec 14, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.06
Upside: +142.72%
Dec 1, 2025
Initiated Coverage: Hold
Price Target: $117
Current: $98.12
Upside: +19.24%
Jul 25, 2025
Reiterated: Buy
Price Target: $290 → $300
Current: $317.95
Upside: n/a
May 20, 2025
Reiterated: Buy
Price Target: $310
Current: $288.89
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: $5 → $4.5
Current: $1.24
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $4 → $3
Current: $1.73
Upside: n/a
Feb 25, 2025
Reiterated: Sell
Price Target: $20 → $11
Current: $3.98
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: $22 → $18
Current: $16.65
Upside: n/a
Aug 1, 2024
Reiterated: Buy
Price Target: $30
Current: $64.00
Upside: n/a
Jun 3, 2024
Reiterated: Buy
Price Target: $11
Current: $6.79
Upside: n/a
Jun 3, 2024
Downgraded: Hold
Price Target: $3
Current: $2.06
Upside: n/a
Jun 3, 2024
Reiterated: Hold
Price Target: $215 → $165
Current: $175.42
Upside: n/a
May 13, 2024
Reiterated: Hold
Price Target: $10 → $6
Current: $3.61
Upside: n/a
Jan 23, 2023
Upgraded: Hold
Price Target: $35 → $18
Current: $17.89
Upside: n/a
Jul 26, 2022
Upgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Apr 28, 2022
Reiterated: Buy
Price Target: $325 → $315
Current: $170.18
Upside: n/a
Apr 1, 2022
Reiterated: Hold
Price Target: $16 → $8
Current: $3.50
Upside: n/a
Mar 23, 2022
Reiterated: Buy
Price Target: $28 → $25
Current: $8.25
Upside: n/a
Mar 15, 2022
Reiterated: Buy
Price Target: $23 → $18
Current: $6.73
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $30 → $15
Current: $0.7644
Upside: n/a
Mar 2, 2022
Reiterated: Buy
Price Target: $40 → $60
Current: $2.87
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $75 → $25
Current: $2.03
Upside: n/a
Feb 28, 2022
Reiterated: Hold
Price Target: $47 → $55
Current: $8.57
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $60 → $50
Current: $24.02
Upside: n/a
Feb 15, 2022
Reiterated: Buy
Price Target: $300 → $310
Current: $266.90
Upside: n/a
Feb 4, 2022
Reiterated: Sell
Price Target: $100 → $65
Current: $132.75
Upside: n/a
Jul 21, 2021
Reiterated: Buy
Price Target: $300 → $333
Current: $426.70
Upside: n/a
May 28, 2021
Reiterated: Buy
Price Target: $375 → $390
Current: $300.15
Upside: n/a
Oct 30, 2020
Reiterated: Buy
Price Target: $27 → $30
Current: $22.90
Upside: n/a
Dec 13, 2017
Downgraded: Sell
Price Target: n/a
Current: $0.1557
Upside: n/a
Mar 1, 2017
Reiterated: Hold
Price Target: $34 → $25
Current: $6.39
Upside: n/a
Aug 4, 2016
Reiterated: Hold
Price Target: $8
Current: $0.6242
Upside: n/a